Skip to main content
Equibles
GEHC logo

GEHC · GE HealthCare Technologies Inc. · Metrics

Track GEHC — free

Use GEHC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GEHC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$65.17 -1.61 (-2.40%) At close · Sep 9
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$30.08B
Shares
454.89M

GEHC metrics

90 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$65.17
Market cap
$30.08B

Price action

20 metrics
Price change (1W)
-5.2%
Price change (30D)
-8.5%
Price change (3M)
+1.2%
Price change (6M)
-8.2%
Price change (YTD)
-18.6%
Price change (1Y)
-14.6%
Trailing year
Price change (5Y)
—
52-week high
$88.16
52-week low
$59.49
Change from 52-week high
-24.3%
Change from 52-week low
+12.3%
Annualized volatility
35.1%
Annualized volatility (3M)
39.9%
Beta
0.8
RSI (14D)
35.1
Price vs SMA 50
-2.3%
Price vs SMA 200
-8.2%
Avg volume (3M)
4.41M
Relative volume
0.7
Average dollar volume
$292.36M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
454.89M

Valuation

12 metrics
P / E (TTM)
16.0
Trailing earnings · reciprocal yield 6.2%
PEG ratio
—
EV / revenue
1.8×
reciprocal yield 55.3%
EV / EBITDA
—
EV / EBIT
14.3×
reciprocal yield 7.0%
P / sales
1.4×
reciprocal yield 69.7%
P / book
2.8
reciprocal yield 35.5%
FCF yield
5.0%
TTM · current market cap
Buyback yield
1.0%
P / FCF
19.8
reciprocal yield 5.0%
P / operating cash flow
14.8
reciprocal yield 6.7%
Earnings yield
6.3%

Historical valuation

8 metrics
P / E historical average (3Y)
19.7×
reciprocal yield 5.1%
P / E historical average (5Y)
19.7×
reciprocal yield 5.1%
EV / revenue historical average (3Y)
2.1×
reciprocal yield 46.9%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 46.9%
EV / EBIT historical average (3Y)
16.4×
reciprocal yield 6.1%
EV / EBIT historical average (5Y)
16.4×
reciprocal yield 6.1%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.2%
Trailing 12 months
Payout ratio
3.4%
Shareholder yield
1.2%
Dividend / share (TTM)
$0.14
Dividend growth YoY
+3.7%
Dividend growth streak
2
Last ex-dividend
2026-07-24

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
39.1%
Operating margin
12.6%
Trailing 12 months
Net margin
9.1%
Gross profit (TTM)
$8.21B
Operating profit (TTM)
$2.65B
Net income (TTM)
$1.91B
Trailing 12 months
Diluted EPS (TTM)
$4.17
FCF margin
7.2%
Effective tax rate
23.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$15.67

Growth

11 metrics
Revenue growth YoY
+7.4%
Year over year
Net income growth YoY
-31.0%
Revenue (TTM)
$20.98B
Trailing 12 months
EPS growth YoY
-30.9%
Shares change YoY
-0.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+4.0%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
+2.5%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-6.2%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
17.9%
Return on assets
5.1%
Debt / equity
0.9
Current ratio
1.2
EBITDA (TTM)
—
Free cash flow (TTM)
$1.52B
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
10.9%
Trailing 12 months
Net cash
−$7.87B
Latest balance sheet
Cash & equivalents
$2.26B
Total assets
$37.12B
Total debt
$10.13B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.03B
Capital expenditures (TTM)
$508.00M
R&D (TTM)
$1.26B
SG&A (TTM)
$4.30B
Stock compensation (TTM)
$143.00M
R&D / revenue
6.0%
Stock compensation / revenue
0.7%

Ownership (13F)

3 metrics
13F filers
1,225
13F filer change QoQ
-53
Institutional ownership
87.5%

Short interest

3 metrics
Short interest
3.8%
Latest settlement · 5.9 days to cover
Days to cover
5.9d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1932393 CUSIP 36266G107 13F (30d) 488 filings 483 filers Visit website Investor relations